Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma

Transplant Proc. 1994 Dec;26(6):3568-9.

Authors

P M Rizzi¹, S D Ryder, J K Ramage, E Gane, J Karani, N Heaton, B Portmann, K C Tan, R Williams

Affiliation

¹ Institute of Liver Studies, King's College Hospital, London, United Kingdom.

PMID: 7527979

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial

MeSH terms

Carcinoma, Hepatocellular / drug therapy*
Carcinoma, Hepatocellular / mortality
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / surgery
Chemotherapy, Adjuvant
Doxorubicin / therapeutic use*
Female
Follow-Up Studies
Humans
Immunosuppression Therapy
Liver Neoplasms / drug therapy*
Liver Neoplasms / mortality
Liver Neoplasms / pathology
Liver Neoplasms / surgery
Liver Transplantation* / mortality
Male
Middle Aged
Recurrence
Retrospective Studies
Survival Rate
Time Factors
alpha-Fetoproteins / analysis

Substances

alpha-Fetoproteins
Doxorubicin